Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Harding Thomas C.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Harding Thomas C. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CLVS / Clovis Oncology Inc See Remarks 3.801
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Harding Thomas C.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Harding Thomas C. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -63 3.801 -1,63 0,98 -62 3.735
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -915 19.487 -4,48 0,98 -899 19.154
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -788 18.590 -4,07 0,98 -775 18.272
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 181 3.864 4,91
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.812 20.402 9,75
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.562 19.378 8,77
2022-10-04 2022-10-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -6 3.683 -0,16 1,29 -8 4.751
2022-10-04 2022-10-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 15 3.689 0,41
2022-09-06 2022-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -172 3.674 -4,47 1,20 -206 4.409
2022-09-06 2022-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.444 17.816 -7,50 1,20 -1.733 21.379
2022-09-06 2022-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 508 3.846 15,22
2022-09-06 2022-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.896 19.260 17,70
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -77 3.338 -2,25 1,46 -112 4.876
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -930 16.364 -5,38 1,46 -1.359 23.908
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -802 15.481 -4,93 1,46 -1.172 22.618
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 181 3.415 5,60
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.813 17.294 11,71
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.563 16.283 10,62
2022-07-06 2022-07-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -7 3.234 -0,22 2,71 -19 8.764
2022-07-06 2022-07-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 16 3.241 0,50
2022-06-03 2022-06-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -218 3.225 -6,33 0,64 -140 2.072
2022-06-03 2022-06-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.504 14.720 -9,27 0,64 -966 9.458
2022-06-03 2022-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 507 3.443 17,27
2022-06-03 2022-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.896 16.224 21,73
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -76 2.936 -2,52 1,97 -150 5.783
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -913 13.328 -6,41 1,97 -1.798 26.253
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -787 12.429 -5,95 1,97 -1.550 24.483
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -181 1.269 -12,48
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.812 12.688 -12,50
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.562 4.688 -24,99
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 181 3.012 6,39
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.812 14.241 14,58
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.562 13.216 13,40
2022-04-05 2022-04-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -7 2.831 -0,25 2,66 -19 7.530
2022-04-05 2022-04-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -16 140 -10,26
2022-04-05 2022-04-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 16 2.838 0,57
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -871 2.822 -23,59 1,87 -1.625 5.266
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -9 1.662 -0,54 1,87 -17 3.101
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -6.780 11.654 -36,78 1,87 -12.651 21.746
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -166 6.850 -2,37 1,87 -310 12.782
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 2.031 4.062 100,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 19 0 -100,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 282 0 -100,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 11.584 34.750 50,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 6.380 6.380
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81.000 81.000
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.031 3.693 122,20
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 19 1.671 1,15
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 11.584 18.434 169,11
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 282 7.016 4,19
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -81 1.652 -4,67 1,94 -157 3.204
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.094 6.734 -13,98 1,94 -2.122 13.061
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -943 6.015 -13,55 1,94 -1.829 11.667
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -182 1.450 -11,15
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.813 14.500 -11,11
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.563 6.250 -20,01
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 182 1.733 11,73
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.813 7.828 30,14
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.563 6.958 28,97
2022-01-04 2022-01-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -7 1.551 -0,45 2,75 -19 4.265
2022-01-04 2022-01-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -16 156 -9,30
2022-01-04 2022-01-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 16 1.558 1,04
2021-12-03 2021-12-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -7 1.542 -0,45 3,00 -21 4.626
2021-12-03 2021-12-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -141 5.395 -2,55 3,00 -423 16.185
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -18 19 -48,65
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -281 282 -49,91
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 18 1.549 1,18
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 281 5.536 5,35
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -62 1.531 -3,89 4,55 -282 6.966
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -903 5.255 -14,66 4,55 -4.109 23.910
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -779 4.346 -15,20 4,55 -3.544 19.774
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -181 1.632 -9,98
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.812 16.313 -10,00
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.562 7.813 -16,66
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 181 1.593 12,82
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.812 6.158 41,69
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.562 5.125 43,84
2021-10-05 2021-10-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -6 1.412 -0,42 4,41 -26 6.227
2021-10-05 2021-10-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -15 172 -8,02
2021-10-05 2021-10-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 15 1.418 1,07
2021-09-03 2021-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -7 1.403 -0,50 4,89 -34 6.861
2021-09-03 2021-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -141 3.563 -3,81 4,89 -689 17.423
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -19 37 -33,93
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -281 563 -33,29
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 19 1.410 1,37
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 281 3.704 8,21
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -62 1.391 -4,27 4,82 -299 6.705
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -901 3.423 -20,84 4,82 -4.343 16.499
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -777 2.511 -23,63 4,82 -3.745 12.103
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -181 1.813 -9,08
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.813 18.125 -9,09
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.563 9.375 -14,29
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 181 1.453 14,23
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.813 4.324 72,20
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.563 3.288 90,61
2021-07-06 2021-07-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 63 187 50,81
2021-07-06 2021-07-01 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -26 1.272 -2,00 5,79 -151 7.365
2021-07-06 2021-07-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 63 1.298 5,10
2021-06-03 2021-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -7 1.235 -0,56 5,63 -39 6.953
2021-06-03 2021-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -131 1.725 -7,06 5,63 -738 9.712
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 18 56 47,37
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 281 844 49,91
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 18 1.242 1,47
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 281 1.856 17,84
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -80 1.224 -6,13 5,54 -443 6.781
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -966 1.575 -38,02 5,54 -5.352 8.726
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -833 729 -53,33 5,54 -4.615 4.039
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -181 1.994 -8,32
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.812 19.938 -8,33
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.562 10.938 -12,50
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 181 1.304 16,12
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.812 2.541 248,56
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.562 1.562
2021-03-15 2021-03-12 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.987 1.123 -63,89 6,00 -11.922 6.738
2021-03-15 2021-03-12 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -7.367 0 -100,00 5,99 -44.128
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -8 3.110 -0,26 6,29 -50 19.562
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -156 7.367 -2,07 6,29 -981 46.338
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -143 7.241 -1,94 6,29 -899 45.546
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 19 74 34,55
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 282 1.125 33,45
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 258 0 -100,00
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 6.090 6.090
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 46.334 46.334
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 19 3.118 0,61
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 282 7.523 3,89
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 258 7.384 3,62
2021-02-19 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -313 3.099 -9,17 8,17 -2.557 25.319
2021-02-19 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -539 2.687 -16,71 8,17 -4.404 21.953
2021-02-19 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -725 2.175 -25,00
2021-02-19 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.250 0 -100,00
2021-02-19 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 725 3.412 26,98
2021-02-19 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.250 3.226 63,26
2021-02-19 3/A CLVS Clovis Oncology, Inc.
Common Stock
1.976
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -4.317 7.126 -37,73 7,97 -34.406 56.794
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -931 4.193 -18,17 7,97 -7.420 33.418
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -7.250 21.750 -25,00
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1.563 12.500 -11,11
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 7.250 11.443 172,91
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1.563 5.124 43,89
2020-12-07 3 CLVS Clovis Oncology, Inc.
Common Stock
3.210
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -281 1.407 -16,65
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -258 258 -50,00
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -98 3.561 -2,68 4,89 -479 17.413
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 281 3.659 8,32
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -90 3.378 -2,60 4,89 -440 16.518
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 258 3.468 8,04
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)